95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.50%
Negative net income growth while AEM stands at 21.87%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while AEM is at 18.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while AEM is at 19.35%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.61%
Share reduction more than 1.5x AEM's 5.20%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.64%
Diluted share reduction more than 1.5x AEM's 5.10%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Negative OCF growth while AEM is at 53.75%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
156.85%
Similar 10Y revenue/share CAGR to AEM's 160.17%. Walter Schloss might see both firms benefiting from the same long-term demand.
-43.56%
Negative 5Y CAGR while AEM stands at 201.27%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
3Y revenue/share CAGR under 50% of AEM's 202.43%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
5Y OCF/share CAGR above 1.5x AEM's 1266.68%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
785.71%
3Y OCF/share CAGR under 50% of AEM's 6742.81%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
5Y net income/share CAGR above 1.5x AEM's 625.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
658.94%
3Y net income/share CAGR above 1.5x AEM's 368.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
698.75%
10Y equity/share CAGR above 1.5x AEM's 153.48%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
729.85%
5Y equity/share CAGR above 1.5x AEM's 217.13%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1036.77%
3Y equity/share CAGR above 1.5x AEM's 117.08%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Similar asset growth to AEM's 3.75%. Walter Schloss finds parallel expansions or investment rates.
2.31%
Positive BV/share change while AEM is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while AEM invests at 10.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.